biomarker

July 1, 2019

Testing for Multiple Biomarkers at a Time Can Increase Early Detection of OC

News

Testing for additional biomarkers along with the well-known biomarker CA125 can improve the detection of early-stage ovarian cancer, a new study shows. The blood-based assay could significantly improve patient survival ... Read more

October 10, 2018

CT45 Protein Predicts Longer Survival Times in Advanced-stage Ovarian Cancer, Study Reports

News

A protein called CT45 predicts which ovarian cancer patients will respond to platinum-based chemotherapy and is associated with extended survival in these patients, being a new prognostic marker for ovarian ... Read more

August 17, 2018August 19, 2018

Silencing GULP1 Gene Aids Ovarian Cancer Progression, Study Suggests

News, Recently Posted

Epigenetic silencing of the GULP1 gene is key for ovarian cancer progression, suggesting it could be used as a prognostic biomarker for the disease, a study found. The study, “Integrated transcriptomic and epigenomic analysis ... Read more

March 13, 2017

Study Analyzes Use of Circulating Tumor Cells as Prognostic Marker in Ovarian Cancer

News

Most women with epithelial ovarian cancer have circulating tumor cells, and among those who recently received their cancer diagnosis, the more such cells they had, the shorter their survival times, ... Read more

March 10, 2017March 10, 2017

Surface Protein, CD151, May Be Marker of Aggressive Serous Ovarian Cancer

News

A protein called CD151 is highly expressed on the surface of high-grade serous carcinoma (HGSC) cells, the most common and lethal subtype of ovarian cancers, recent research found. Expression of this ... Read more

February 17, 2017February 17, 2017

Tiny Vesicles in the Blood Might Distinguish Ovarian Cancers from Benign Tumors

News

Blood levels of a molecule called phosphatidylserine (PS) may help distinguish between malignant and benign ovarian tumors, researchers report. The study resulted from the collaboration between researchers at the University ... Read more

July 25, 2016July 25, 2016

‘Liquid DNA Biopsy’ Helps to Spot Ovarian Cancer Patients at Risk of Relapse

News

Ovarian cancer relapses may be effectively monitored and, possibly, detected early by analyzing patients’ DNA in blood samples, Mayo Clinic researchers report in the study, “Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers,” published in the ... Read more